Latest Regulatory Engagement News

Pilot Energy has made significant strides in its offshore Perth Basin exploration with environmental approval for a major seismic survey and secured substantial financing to support its ongoing projects and transition to clean energy.

Cleo Diagnostics has secured positive FDA feedback and nearly 1,600 biobank samples, accelerating its ovarian cancer blood test development ahead of a planned 2026 U.S. market entry.

Heavy Minerals Limited is finalising its Port Gregory Garnet Project Pre-Feasibility Study with a report due in November 2025, while advancing a promising industrial minerals project towards a binding agreement expected this quarter.

Santana Minerals reports robust progress on its Bendigo-Ophir Gold Project with an updated Pre-Feasibility Study, strategic land acquisitions, and a substantial capital raise, positioning the project for development in 2026.

Kingsrose Mining advances exploration in Norway’s Finnmark region with new geophysical anomalies, while navigating permitting challenges in Finland and focusing on strategic M&A under new leadership.

Cooper Metals is gearing up for drilling at its Mt Isa East copper-gold project while divesting a majority stake in its Gilberton Gold Project to Sybella Metals, maintaining a solid cash position to fund exploration.

Alterity Therapeutics reports strengthened efficacy signals for ATH434 in Multiple System Atrophy and secures a robust cash position to fuel upcoming Phase 3 trials.

Felix Gold Limited has made significant strides in transitioning its Treasure Creek project from exploration to operational readiness, positioning itself as a key domestic supplier of critical antimony for the U.S. market.

TrivarX has reported promising interim results from its US veteran-focused mental health trial using ECG technology, while progressing a strategic acquisition of novel brain tumor imaging IP to broaden its diagnostic portfolio.

Yugo Metals has raised $3.5 million to fund its first-ever diamond drilling program targeting gold anomalies at its Sinjakovo project in Bosnia. The company also advances community and regulatory engagement for its Sockovac license while maintaining a cautious cash position.

Echo IQ Limited has advanced its EchoSolv heart failure solution towards FDA submission, driven by a landmark clinical validation study and a sharp rise in US platform adoption. Strategic partnerships and international expansion efforts underscore the company’s growing footprint in cardiology AI.

Elementos Limited advances its Oropesa Tin Project in Spain and Cleveland Tin Project in Tasmania, securing a binding option to acquire 50% of a Spanish tin smelter, positioning itself as the European Union’s primary vertically integrated tin producer amid strong tin prices.